• 2017 February Digital Edition

    by on February 27th, 2017
  • Diabetes Drug Adherence Rates: How mHealth Makes a Difference

    Adherence Solutions by on February 24th, 2017

    Medicine can’t work when it’s not taken. It sounds simple: “Take your meds as prescribed.” But with multiple doses per day and/or several medications to take, it can quickly become confusing. A combination of rising medication costs, poor self-management, insufficient education, and lack of support have led to poor medication adherence among patients. Research shows […]

  • Point of Care: Strategy, Tactic, or Something More?

    by on February 24th, 2017

    Several of PM360’s 2016 Brand Champion Award Winners gathered before the Trailblazers Awards Gala last year to discuss the many ways that point of care marketing is used to educate and engage patients, HCPs, NPs, PAs, and others to improve brand success and patient outcomes. PM360’s Success Coach columnist, Bud Bilanich, moderated the event. Participants […]

  • The Impact of AI and Machine Learning in Marketing

    E-Source by on February 24th, 2017

    In the new world of artificial intelligence and machine learning, predictive content is digital content that automatically assembles itself in real-time for each impression with deep and precise predictive intelligence. In marketing and consumer engagement, this is as close to personalization at scale that we, as marketers, have to date. Up until now, many have […]

  • Risk/Outcomes Contracting Has Finally Arrived

    Feature Articles by on February 24th, 2017

    In our organization’s payer market research, we generally find pharmacy and medical directors respond to proposed risk- or outcomes-based contracting with muted interest. The reasons often include cost of contract management, lack of internal staff and infrastructure to extract and report the data, and inconsistent data availability across their membership. Among insurers and networks, electronic […]

  • Avoid the Price Crisis

    Feature Articles by on February 24th, 2017

    Reputational crisis. This is the best expression to describe the worsening relationship between the biopharmaceutical industry and the very people it seeks to serve. Today, companies that make medicines to save or improve peoples’ lives are less respected than law firms and oil companies.1 One study even shows that the number of Americans who believe […]

  • Making Step Therapy Work for Patients, Providers, and Payers

    Feature Articles by on February 24th, 2017

    The use of step therapy protocols by payers to manage pharmacy costs has increased significantly over the past several years. According to Health Strategies Group, in 2015, 39% of health plans used step therapy in at least 12 classes of medications—an increase of 35% over the prior year. At its core, step therapy is about […]

  • From Obamacare to Trumpcare: America Readies for Change

    Guest Commentary by on February 24th, 2017

    The Affordable Care Act (ACA) has been a magnet for heated Beltway conversation since inception. Health cost, benefits, and perceptions fueled debate on the future of the nation’s nascent “insurance for everyone” program throughout the elections. Yet, the surge in ACA enrollment during the Obama Administration’s last weeks signaled that for the uninsured, “getting on […]

  • Overcoming the Challenges of Step Therapy

    Feature Articles by on February 24th, 2017

    Step therapy, or “fail first” as it is sometimes called, requires patients to first attempt treatment with one drug before the payer will allow coverage of the treatment initially prescribed by the physician. Payers implement these protocols as a way to manage costs by first steering a patient to a generic or formulary-preferred drug. This […]

  • How Media Data & Analytics are Transforming Strategy and Engagement

    The pharmaceutical industry is beginning to embrace the world of analytics and deep customer understanding that’s been established in other industries, and it’s happening just in time. Pharma companies are under more scrutiny, regulatory pressure, and financial pressure than ever before. The competition is getting heated due to specialty drugs, biologics, and biosimilars. This environment […]

  • Healthcare Watch February 2017

    Healthcare Watch by on February 24th, 2017

    Sales Sector: Estimated Top Selling Drugs Slated to Launch in 2017 Novo Nordisk’s once-weekly type 2 diabetes treatment semaglutide, is expected to be the most successful small-molecule drug launched in 2017, according to EvaluatePharma, a market intelligence firm that forecasts prescription drug sales. Semaglutide is predicted to reach $2 billion in sales by 2022 with […]

  • Physician-Industry Collaboration: How to Maintain Compliance

    Throughout the medical device industry, physicians are used to teach and train fellow physicians and company sales reps on new products and surgical procedures. But with increased scrutiny on physician-industry interactions and the advent of Sunshine Act reporting, the industry faces a potential compliance minefield with this collaboration. While every company wants to find known, […]

  • Sticking with New Year’s Resolutions: There’s An App For That

    LifeStyle by on February 24th, 2017

    This time of year your resolve to read more, workout, or eat better may be starting to wane. But fear not, for any resolution, now there is an app to keep you on track, even if you’ve promised to give up looking at your smartphone so often. These are our top picks for fun apps […]

Back to top